Literature DB >> 7763277

Species differences in hydrolysis of isocarbacyclin methyl ester (TEI-9090) by blood esterases.

T Minagawa1, Y Kohno, T Suwa, A Tsuji.   

Abstract

Species differences in the hydrolysis of isocarbacyclin methyl ester (TEI-9090) in whole blood and in its separated components were studied in rats, dogs and human. Esterase activity in rat whole blood was approximately 100 and 400 times higher than that in dog and human whole blood, respectively, and was attributed to high plasma activity. In contrast, TEI-9090 hydrolysis activities in dog and human blood were due to red blood cells (RBC), whose activity in humans was slightly suppressed by albumin. In dogs, activity in RBC membranes was 10 times greater than in the cytosol, while in human membrane and cytosol activity was virtually the same. The effects of the esterase inhibitor diisopropylfluorophosphate, bis-p-nitrophenylphosphate (BNPP), eserine, 5,5'-dithiobis-(2-nitrobenzoic acid) (DTNB) and p-chloromercuribenzoate showed that the rat plasma and RBC cytosol esterases hydrolysing TEI-9090 were carboxylesterase (CarbE) and arylesterase (ArE), respectively. The esterases in dog plasma and RBC membrane were CarbE, and RBC cytosol esterase was ArE. In humans, the esterase activities in plasma, RBC membrane and cytosol were butyrylcholinesterase, CarbE and ArE, respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7763277     DOI: 10.1016/0006-2952(95)00071-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

Review 1.  Factors influencing the use and interpretation of animal models in the development of parenteral drug delivery systems.

Authors:  Marilyn N Martinez
Journal:  AAPS J       Date:  2011-10-05       Impact factor: 4.009

2.  Anchimerically Activatable Antiviral ProTides.

Authors:  Aniekan Okon; Marcos Romário Matos de Souza; Rachit Shah; Raquel Amorim; Luciana Jesus da Costa; Carston R Wagner
Journal:  ACS Med Chem Lett       Date:  2017-08-14       Impact factor: 4.345

3.  Human α/β hydrolase domain containing 10 (ABHD10) is responsible enzyme for deglucuronidation of mycophenolic acid acyl-glucuronide in liver.

Authors:  Atsushi Iwamura; Tatsuki Fukami; Ryota Higuchi; Miki Nakajima; Tsuyoshi Yokoi
Journal:  J Biol Chem       Date:  2012-01-31       Impact factor: 5.157

4.  Pharmacokinetics of amino acid phosphoramidate monoesters of zidovudine in rats.

Authors:  Heng Song; George W Griesgraber; Carston R Wagner; Cheryl L Zimmerman
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

5.  Characterization of pulmonary alveolar esterases of the primate Cercopithecus pygerythrus.

Authors:  H M Leng; J A Syce
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

6.  Selective effects of a morphine conjugate vaccine on heroin and metabolite distribution and heroin-induced behaviors in rats.

Authors:  M D Raleigh; M Pravetoni; A C Harris; A K Birnbaum; P R Pentel
Journal:  J Pharmacol Exp Ther       Date:  2012-12-07       Impact factor: 4.030

7.  Stability of heroin, 6-monoacetylmorphine, and morphine in biological samples and validation of an LC-MS assay for delayed analyses of pharmacokinetic samples in rats.

Authors:  Jessica M Jones; Michael D Raleigh; Paul R Pentel; Theresa M Harmon; Daniel E Keyler; Rory P Remmel; Angela K Birnbaum
Journal:  J Pharm Biomed Anal       Date:  2012-11-15       Impact factor: 3.935

8.  Real-time bioluminescence imaging of glycans on live cells.

Authors:  Allison S Cohen; Elena A Dubikovskaya; Jason S Rush; Carolyn R Bertozzi
Journal:  J Am Chem Soc       Date:  2010-06-30       Impact factor: 15.419

9.  Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.

Authors:  S Shaukat Husain; Ervin Pejo; Rile Ge; Douglas E Raines
Journal:  Anesthesiology       Date:  2012-11       Impact factor: 7.892

10.  Pharmacokinetics and metabolism of 14C-levetiracetam, a new antiepileptic agent, in healthy volunteers.

Authors:  Margherita Strolin Benedetti; Rhys Whomsley; Jean-Marie Nicolas; Colin Young; Eugène Baltes
Journal:  Eur J Clin Pharmacol       Date:  2003-10-07       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.